[1] |
Murphy D,McCulloch CE,Lin F, et al. Trends in prevalence of chronic kidney disease in the United States [J]. Ann Intern Med, 2016, 165(7): 473-481.
|
[2] |
Chudek J,Wieczorowska-Tobis K,Zejda J, et al. The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study PolSenior [J]. Nephrol Dial Transplant, 2014, 29(5): 1073-1082.
|
[3] |
Zhang L,Wang F,Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
|
[4] |
National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update [J]. Am J Kidney Dis, 2012, 60(5): 850-886.
|
[5] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease [J]. Kidney Int Suppl, 2013, 3: 1-150.
|
[6] |
上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.
|
[7] |
Andrassy KM. Comments on ′KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease′ [J]. Kidney Int, 2013, 84(3): 622-623.
|
[8] |
Earley A,Miskulin D,Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review [J]. Ann Intern Med, 2012, 156(11): 785-795.
|
[9] |
Schold JD,Navaneethan SD,Jolly SE, et al. Implications of the CKD-EPI GFR estimation equation in clinical practice [J]. Clin J Am Soc Nephrol, 2011, 6(3): 497-504.
|
[10] |
Benghanem Gharbi M,Elseviers M,Zamd M, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over" - and "under" -diagnosis of CKD [J]. Kidney Int, 2016, 89(6): 1363-1371.
|
[11] |
Peralta CA,Katz R,Sarnak MJ, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications [J]. J Am Soc Nephrol, 2011, 22(1): 147-155.
|
[12] |
Brook MO,Bottomley MJ,Mevada C, et al. Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk [J]. QJM, 2012, 105(3): 247-255.
|
[13] |
Arora P,Jalal K,Gupta A, et al. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients [J]. Int Urol Nephrol, 2017, 49(6): 1033-1040.
|
[14] |
Johansson L,Fouque D,Bellizzi V, et al. As we grow old: nutritional considerations for older patients on dialysis [J]. Nephrol Dial Transplant, 2017, 32(7): 1127-1136.
|
[15] |
Brunori G,Viola BF,Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study [J]. Am J Kidney Dis, 2007, 49(5): 569-580.
|
[16] |
Windahl K,Faxen Irving G,Almquist T, et al. Prevalence and risk of protein-energy wasting assessed by subjective global assessment in older adults with advanced chronic kidney disease: results from the EQUAL study [J]. J Ren Nutr, 2018, 28(3): 165-174.
|
[17] |
Farrington K,Covic A,Nistor I, et al. Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group [J]. Nephrol Dial Transplant, 2017, 32(1): 9-16.
|
[18] |
Slinin Y,Guo H,Gilbertson DT, et al. Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis [J]. Am J Kidney Dis, 2011, 58(4): 583-590.
|
[19] |
Fischer MJ,O′Hare AM. Epidemiology of hypertension in the elderly with chronic kidney disease [J]. Adv Chronic Kidney Dis, 2010, 17(4): 329-340.
|
[20] |
James PA,Oparil S,Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [J]. JAMA, 2014, 311(5): 507-520.
|
[21] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [J]. Kidney Int Suppl, 2012, 2: 337-414.
|
[22] |
中国医师协会肾脏内科医师分会,中国中西医结合学会肾脏疾病专业委员会.中国肾性高血压管理指南2016[J].中华医学杂志,2017,97(20):1547-1555.
|
[23] |
Carey RM,Whelton PK, 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline [J]. Ann Intern Med, 2018, 168(5): 351-358.
|
[24] |
Ogurtsova K,da Rocha Fernandes JD,Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040 [J]. Diabetes Res Clin Pract, 2017, 128: 40-50.
|
[25] |
Robles NR,Felix FJ,Fernandez-Berges D, et al. Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish survey [J]. Int Urol Nephrol, 2013, 45(2): 553-560.
|
[26] |
Russo GT,De Cosmo S,Viazzi F, et al. Diabetic kidney disease in the elderly: prevalence and clinical correlates [J]. BMC Geriatr, 2018, 18(1): 38.
|
[27] |
Bertoluci MC,Moreira RO,Faludi A, et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [J]. Diabetol Metab Syndr, 2017, 9: 53.
|
[28] |
Lipska KJ,Krumholz H,Soones T, et al. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes [J]. JAMA, 2016, 315(10): 1034-1045.
|
[29] |
Tonelli M,Wiebe N,James MT, et al. A population-based cohort study defines prognoses in severe chronic kidney disease [J]. Kidney Int, 2018, 93(5): 1217-1226.
|
[30] |
Thomas B,Matsushita K,Abate KH, et al. Global cardiovascular and renal outcomes of reduced GFR [J]. J Am Soc Nephrol, 2017, 28(7): 2167-2179.
|
[31] |
James MT,Tonelli M,Ghali WA, et al. Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study [J]. BMJ, 2013, 347: f4151.
|
[32] |
Lau JK,Anastasius MO,Hyun KK, et al. Evidence-based care in a population with chronic kidney disease and acute coronary syndrome [J]. Am Heart J, 2015, 170(3): 566-572.
|
[33] |
Klawansky S,Komaroff E,Cavanaugh PF Jr., et al. Relationship between age, renal function and bone mineral density in the US population [J]. Osteoporos Int, 2003, 14(7): 570-576.
|
[34] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) [J]. Kidney Int Suppl, 2017, 7: 1-59.
|
[35] |
Nitta K,Yajima A,Tsuchiya K. Management of osteoporosis in chronic kidney disease [J]. Intern Med, 2017, 56(24): 3271-3276.
|
[36] |
St Peter WL,Guo H,Kabadi S, et al. Prevalence, treatment patterns, and healthcare resource utilization in medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States [J]. BMC Nephrol, 2018, 19(1): 67.
|
[37] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease [J]. Kidney Int Suppl, 2012, 2: 283-335.
|
[38] |
Mikhail A,Brown C,Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease [J]. BMC Nephrol, 2017, 18(1): 345.
|
[39] |
Yaffe K,Ackerson L,Kurella Tamura M, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study [J]. J Am Geriatr Soc, 2010, 58(2): 338-345.
|
[40] |
Chen YC,Weng SC,Liu JS, et al. Severe decline of estimated glomerular filtration rate associates with progressive cognitive deterioration in the elderly: a community-based cohort study [J]. Sci Rep, 2017, 7: 42690.
|
[41] |
Raphael KL,Wei G,Greene T, et al. Cognitive function and the risk of death in chronic kidney disease [J]. Am J Nephrol, 2012, 35(1): 49-57.
|
[42] |
Bronas UG,Puzantian H,Hannan M. Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of exercise [J]. Biomed Res Int, 2017, 2017: 2726369.
|
[43] |
Feng L,Yap KB,and Ng TP. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates [J]. Am J Geriatr Psychiatry, 2013, 21(6): 570-579.
|
[44] |
Hedayati SS,Gregg LP,Carmody T, et al. Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial [J]. JAMA, 2017, 318(19): 1876-1890.
|